Cardio Med S.R.L.
- Address
- lock Available on a paid plan
Cardiovascular Diseases Research
At Cardio Med S.R.L. in Craiova, the main focus is on cardiology studies within cardiovascular diseases, especially in people with high cardiovascular risk, atherosclerotic cardiovascular disease, and established heart and blood vessel conditions. These trials are designed to test new treatment approaches and better understand how to reduce serious events such as heart attack and stroke.
- Preventing major cardiovascular events in adults at high risk without prior heart attack or stroke
- Studying therapies for established atherosclerotic cardiovascular disease and broader cardiovascular disease
- Evaluating treatments aimed at lowering the risk of death, stroke, and urgent revascularization
The research also includes efforts to improve long-term management of patients with ongoing cardiovascular conditions, supporting safer and more effective care.
Nutritional and Metabolic Diseases Research
Another important area at this site is nutritional and metabolic diseases, with studies looking at conditions linked to hypertension, kidney disease, inflammation, and abnormal lipid-related risk. The trials explore whether new therapies can improve outcomes in patients whose cardiovascular health is affected by metabolic and inflammatory factors.
- Testing treatments for hypertension that is not adequately controlled
- Assessing therapies in people with chronic kidney disease and systemic inflammation
- Exploring approaches that may reduce cardiovascular risk linked to elevated lipoprotein(a)
These studies aim to refine treatment strategies for patients whose heart disease risk is shaped by metabolic disorders and related complications.
Heart Failure and Advanced Cardiovascular Care
Clinical research at this hospital/clinic also includes studies in heart failure, particularly heart failure with reduced ejection fraction. The goal is to evaluate new options that may help improve symptoms, safety, and overall treatment effectiveness for people living with this serious condition.
- Investigating potential therapies for heart failure with reduced ejection fraction
- Checking safety and tolerability in patients with chronic cardiac dysfunction
- Supporting better understanding of how emerging treatments perform in everyday care
These trials reflect a strong interest in advancing care for patients with complex and high-risk cardiovascular disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
- 1Novartis Pharma AG1active
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG5trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Cardio Med S.R.L.
lock Showing 1 of 16 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Sotagliflozin in Patients with Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy | Lexicon Pharmaceuticals Inc. | Phase III | Recruiting | Jun 2025 | — |
IMP list
lock Showing 1 of 15 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Inclisiran | 3 | Unknown | 2021-11-26 | 2023-09-04 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.